|
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Millions, unless otherwise specified
|
9 Months Ended |
|
Sep. 30, 2012
|
Sep. 30, 2011
|
| Operating Activities |
|
|
| Net Income |
$ 535 |
$ 563 |
| Adjustments to reconcile net income to net cash from operating activities: |
|
|
| Depreciation, depletion and amortization |
747 |
752 |
| Deferred income taxes |
96 |
123 |
| Asset (gains), losses and reserves and impairments, net |
(7) |
0 |
| Changes in assets and liabilities, exclusive of changes shown separately (Note 14) |
358 |
48 |
| Net cash from operating activities |
1,729 |
1,486 |
| Investing Activities |
|
|
| Plant and equipment expenditures — utility |
(1,008) |
(968) |
| Plant and equipment expenditures — non-utility |
(214) |
(61) |
| Proceeds from sale of assets |
20 |
13 |
| Restricted cash for debt redemption, principally Securitization |
55 |
47 |
| Proceeds from sale of nuclear decommissioning trust fund assets |
48 |
69 |
| Investment in nuclear decommissioning trust funds |
(61) |
(97) |
| Other |
(24) |
(55) |
| Net cash used for investing activities |
(1,184) |
(1,052) |
| Financing Activities |
|
|
| Issuance of long-term debt |
495 |
908 |
| Redemption of long-term debt |
(447) |
(1,161) |
| Short-term borrowings, net |
(321) |
126 |
| Issuance of common stock |
29 |
0 |
| Repurchase of common stock |
0 |
(18) |
| Dividends on common stock |
(300) |
(289) |
| Other |
(10) |
(19) |
| Net cash used for financing activities |
(554) |
(453) |
| Net Increase (Decrease) in Cash and Cash Equivalents |
(9) |
(19) |
| Cash and Cash Equivalents at Beginning of Period |
68 |
65 |
| Cash and Cash Equivalents at End of Period |
$ 59 |
$ 46 |